FCE
AMPH icon

Fiera Capital (Europe)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Fiera Capital (Europe)’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,671
Closed -$235K – 42
2016
Q2 		$235K Hold
14,671
– – 0.18% 30
2016
Q1 		$177K Hold
14,671
– – 0.17% 33
2015
Q4 		$210K Buy
14,671
+6,220
+74% +$82.2K 0.25% 32
2015
Q3 		$98K Hold
8,451
– – 0.13% 46
2015
Q2 		$149K Hold
8,451
– – 0.14% 37
2015
Q1 		$126K Sell
8,451
-113,125
-93% -$1.51M 0.11% 40
2014
Q4 		$1.43M Buy
+121,576
New +$1.32M 1.05% 19

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fiera Capital (Europe)'s AMPH Position: Q3 2016 in Review

Fiera Capital (Europe) sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2016, closing a stake of 14,671 shares — an estimated $235K sold.

Fiera Capital (Europe) first reported a position in AMPH in Q4 2014 and held it in 7 quarters. The position peaked at $1.43M in Q4 2014. 135 funds tracked by Wall St. Rank hold AMPH as of Q3 2016.

  • Fiera Capital (Europe) reported no remaining Amphastar Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Fiera Capital (Europe) sold 14,671 Amphastar Pharmaceuticals shares in Q3 2016, an estimated $235K.
  • Fiera Capital (Europe) first reported a position in Amphastar Pharmaceuticals in Q4 2014 and held it in 7 quarters.
  • Fiera Capital (Europe)'s Amphastar Pharmaceuticals position peaked at $1.43M in Q4 2014.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2016.

Based on Fiera Capital (Europe)'s 13F filing for Q3 2016, filed 10 Nov 2016.